M. COLOT

424 total citations
22 papers, 343 citations indexed

About

M. COLOT is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, M. COLOT has authored 22 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in M. COLOT's work include Carcinogens and Genotoxicity Assessment (4 papers), Synthesis and Reactivity of Heterocycles (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). M. COLOT is often cited by papers focused on Carcinogens and Genotoxicity Assessment (4 papers), Synthesis and Reactivity of Heterocycles (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). M. COLOT collaborates with scholars based in Austria, United States and Slovakia. M. COLOT's co-authors include M. Micksche, Leonilla Elbling, TA Luger, J Charon, J J Oppenheim, A Köck, Yoshiaki Uchida, Thomas A. Luger, E. M. Kokoschka and H. Rainer and has published in prestigious journals such as The Journal of Immunology, British Journal of Cancer and British Journal of Dermatology.

In The Last Decade

M. COLOT

21 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. COLOT Austria	8	159	76	65	41	40	22	343
K Shimoda Japan	15	86 0.5×	119 1.6×	101 1.6×	27 0.7×	105 2.6×	35	552
Å. Bengtsson Sweden	12	170 1.1×	119 1.6×	79 1.2×	116 2.8×	21 0.5×	16	500
Chaline Johnson United States	9	117 0.7×	84 1.1×	70 1.1×	5 0.1×	68 1.7×	12	440
Louis Dubertret France	7	349 2.2×	50 0.7×	52 0.8×	214 5.2×	18 0.5×	8	469
Bruce E. Ogden United States	7	193 1.2×	80 1.1×	19 0.3×	63 1.5×	33 0.8×	7	521
Mohammad Vodjgani Iran	9	167 1.1×	83 1.1×	24 0.4×	9 0.2×	24 0.6×	22	342
C. Buicu Belgium	6	307 1.9×	214 2.8×	78 1.2×	5 0.1×	85 2.1×	9	463
Tsuyoshi Igarashi Japan	12	268 1.7×	79 1.0×	14 0.2×	7 0.2×	41 1.0×	28	441
J.-M. Geiger Switzerland	17	453 2.8×	417 5.5×	111 1.7×	358 8.7×	14 0.3×	30	823
T. Timonen Finland	12	133 0.8×	115 1.5×	52 0.8×	3 0.1×	59 1.5×	25	426

Countries citing papers authored by M. COLOT

Since Specialization

Citations

This map shows the geographic impact of M. COLOT's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. COLOT with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. COLOT more than expected).

Fields of papers citing papers by M. COLOT

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. COLOT. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. COLOT. The network helps show where M. COLOT may publish in the future.

Co-authorship network of co-authors of M. COLOT

This figure shows the co-authorship network connecting the top 25 collaborators of M. COLOT. A scholar is included among the top collaborators of M. COLOT based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. COLOT. M. COLOT is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elbling, Leonilla & M. COLOT. (1987). Persistence of SCE-inducing damage in mouse embryos and fetuses following superovulation. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 176(1). 117–122. 12 indexed citations

Elbling, Leonilla & M. COLOT. (1986). In vitro SCE discrepancy between embryonic and extraembryonic mouse tissues. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 163(2). 175–180. 2 indexed citations

Luger, Thomas A., Yoshiaki Uchida, A Köck, M. COLOT, & M. Micksche. (1985). Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.. The Journal of Immunology. 134(4). 2477–2483. 32 indexed citations

Elbling, Leonilla & M. COLOT. (1985). Abnormal development and transport and increased sister-chromatid exchange in preimplantation embryos following superovulation in mice. Mutation Research/Environmental Mutagenesis and Related Subjects. 147(4). 189–195. 59 indexed citations

Elbling, Leonilla & M. COLOT. (1985). A method for analysing sister-chromatid exchange in mouse preimplantation embryos. Mutation Research/Environmental Mutagenesis and Related Subjects. 147(1-2). 23–28. 5 indexed citations

Luger, Thomas A., et al.. (1985). Production of distinct cytokines by epidermal cells. British Journal of Dermatology. 113(s28). 145–156. 25 indexed citations

COLOT, M., et al.. (1985). [Derivatives of decahydroquinoline. Study and pharmacologic screening of carbamates and esters of N-benzoylalkylated 4-hydroxy decahydroquinolines and corresponding dioxane compound].. PubMed. 43(2). 139–46. 1 indexed citations

Uchida, Yoshiaki, M. COLOT, & M. Micksche. (1984). Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells. British Journal of Cancer. 49(1). 17–23. 15 indexed citations

Prost, Michel, et al.. (1983). ChemInform Abstract: RESEARCH IN THE INDOLIZINES SERIES. IV. EFFECT OF SUBSTITUTION IN THE NEIGHBORHOOD OF ETHER FUNCTION IN THE BUTOPROZINE SERIES. Chemischer Informationsdienst. 14(11). 1 indexed citations

10.

Micksche, M., et al.. (1982). Plasmapheresis in Patients with Advanced Malignant Disease: A Pilot Study. Oncology. 39(3). 146–151. 9 indexed citations

11.

COLOT, M., et al.. (1982). ChemInform Abstract: CARDIOVASCULAR POTENTIAL OF PIPERAZINOISOPROPANOLOXY DERIVATIVES OF PYRIDOXINE. Chemischer Informationsdienst. 13(48). 1 indexed citations

12.

COLOT, M. & M. Micksche. (1982). Influence of Thia-Benzimidazole Wy 18251 of Cancer Patients Lymphocyte Reactivity. PubMed. 4(4). 367–376. 4 indexed citations

13.

COLOT, M., et al.. (1981). デカヒドロキノレイン誘導体 VII N‐アリールオキシアルキル化‐4‐ヒドロキシデカヒドロキノレインのカルバメートおよびエステル. 16(2). 119–123.

14.

COLOT, M., et al.. (1980). Variability in the preventive action of the B-blockers on genetic hypertension in the rat.. PubMed. 6(4). 227–31. 1 indexed citations

15.

COLOT, M., M. Micksche, & U. Bicker. (1979). Enhanced PHA stimulation of cancer patients' lymphocytes by addition of BM 12531 (azimexon) in vitro. Cancer Immunology Immunotherapy. 6(3). 4 indexed citations

16.

COLOT, M., et al.. (1975). Indolizinyl pyridyl ketones synthesis and evaluation of their anti inflammatory and analgesic activities. 10(6). 579–584. 1 indexed citations

17.

COLOT, M., et al.. (1974). [Research on the indole series. II. Anti-inflamatory and anti-arthritic properties of (isopropyl-2 indolyl)-3 pyridil-3 ketone].. PubMed. 28(4). 775–98. 7 indexed citations

18.

COLOT, M., et al.. (1973). Recherches dans la série des indoles. II. Propriétés anti-inflammatoires et anti-arthritiques de l'(isopropyl-2 indolyl)-3 pyridyl-3 cétone. Therapies. 28(4). 1 indexed citations

19.

COLOT, M., et al.. (1972). [Research on benzofuran series. XLV. Pharmacological properties of exetorone].. PubMed. 26(6). 1135–54. 1 indexed citations

20.

Charlier, Robert, et al.. (1970). [Studies on substances in the benzofuran group. 43. Angiotrophic, anti-inflammatory and fibrinolytic properties of benzarone].. PubMed. 20(3). 358–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact